Yonkers Newswire

Comprehensive Real-Time News Feed for Yonkers, NY.

Results 1 - 11 of 11 for "u:americanbankingnews.com" in Yonkers, NY

  1. Analyzing XOMARead the original story w/Photo

    Sunday Jan 21 | AmericanBankingNews.com

    XOMA and ContraFect are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, profitability and dividends. 33.5% of XOMA shares are owned by institutional investors.

    Comment?

  2. Head to Head Comparison: ContraFectRead the original story w/Photo

    Sunday Jan 7 | AmericanBankingNews.com

    Mateon Therapeutics and ContraFect are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, profitability, earnings and institutional ownership. Mateon Therapeutics has a beta of 1.5, indicating that its stock price is 50% more volatile than the S&P 500.

    Comment?

  3. Comparing ContraFectRead the original story w/Photo

    Thursday Dec 28 | AmericanBankingNews.com

    ContraFect and Mirati Therapeutics are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, profitability, risk, earnings and dividends. Mirati Therapeutics is trading at a lower price-to-earnings ratio than ContraFect, indicating that it is currently the more affordable of the two stocks.

    Comment?

  4. ContraFect (CFRX) and Windtree Therapeutics (WINT) Critical AnalysisRead the original story w/Photo

    Nov 25, 2017 | AmericanBankingNews.com

    ContraFect and Windtree Therapeutics are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, institutional ownership, dividends, valuation and earnings. ContraFect has higher revenue, but lower earnings than Windtree Therapeutics.

    Comment?

  5. Critical Comparison: ContraFect CorporationRead the original story w/Photo

    Nov 8, 2017 | AmericanBankingNews.com

    ContraFect Corporation and Dendreon are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, institutional ownership, analyst recommendations, earnings and valuation. 24.5% of ContraFect Corporation shares are held by institutional investors.

    Comment?

  6. ContraFect Corporation (CFRX) versus Affymax (AFFY) Financial ComparisonRead the original story w/Photo

    Oct 28, 2017 | AmericanBankingNews.com

    ContraFect Corporation and Affymax are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, risk, profitability and valuation. ContraFect Corporation has a beta of -0.82, indicating that its stock price is 182% less volatile than the S&P 500.

    Comment?

  7. ContraFect Corporation (CFRX) vs. The Competition Critical AnalysisRead the original story w/Photo

    Sep 29, 2017 | AmericanBankingNews.com

    ContraFect Corporation is one of 94 publicly-traded companies in the "Biotechnology" industry, but how does it compare to its rivals? We will compare ContraFect Corporation to related companies based on the strength of its analyst recommendations, earnings, risk, dividends, institutional ownership, profitability and valuation. ContraFect Corporation's rivals have higher revenue and earnings than ContraFect Corporation.

    Comment?

  8. Critical Comparison: ContraFect Corporation (CFRX) versus Its PeersRead the original story w/Photo

    Sep 27, 2017 | AmericanBankingNews.com

    ContraFect Corporation is one of 94 public companies in the "Biotechnology" industry, but how does it contrast to its rivals? We will compare ContraFect Corporation to related businesses based on the strength of its valuation, dividends, risk, analyst recommendations, institutional ownership, earnings and profitability. ContraFect Corporation has a beta of -0.86, indicating that its share price is 186% less volatile than the S&P 500.

    Comment?

  9. Analyzing ContraFect Corporation (CFRX) and The CompetitionRead the original story w/Photo

    Sep 17, 2017 | AmericanBankingNews.com

    ContraFect Corporation is one of 93 public companies in the "Biotechnology" industry, but how does it contrast to its peers? We will compare ContraFect Corporation to similar companies based on the strength of its dividends, institutional ownership, profitability, analyst recommendations, risk, valuation and earnings. 24.5% of ContraFect Corporation shares are owned by institutional investors.

    Comment?

  10. Contrasting ContraFect Corporation (CFRX) & its RivalsRead the original story w/Photo

    Sep 10, 2017 | AmericanBankingNews.com

    ContraFect Corporation is one of 93 public companies in the "Biotechnology" industry, but how does it weigh in compared to its competitors? We will compare ContraFect Corporation to related companies based off the strength of its institutional ownership, earnings, analyst recommendations, risk, valuation, dividends and profitability. 24.5% of ContraFect Corporation shares are held by institutional investors.

    Comment?

  11. Contrasting ContraFect CorporationRead the original story w/Photo

    Sep 3, 2017 | AmericanBankingNews.com

    ContraFect Corporation and Tetralogic Pharmaceuticals Corp are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, institutional ownership and risk. 24.5% of ContraFect Corporation shares are held by institutional investors.

    Comment?

Yonkers Job Listings
View or post Yonkers job listings on Topix.
Yonkers Real Estate
News, listings, and foreclosures in Yonkers from Topix.
Yonkers Mortgages
Find mortgage rates in Yonkers on Topix.